The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

PDL BioPharma Completes Regular Quarterly Dividend Payment

Friday, September 14, 2012

PDL BioPharma Completes Regular Quarterly Dividend Payment16:00 EDT Friday, September 14, 2012INCLINE VILLAGE, Nev., Sept. 14, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the September 14, 2012, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of September 7, 2012, the record date. (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com. NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc. SOURCE PDL BioPharma, Inc.For further information: Bruce Tomlinson, PDL BioPharma, Inc., +1-775-832-8500, Bruce.Tomlinson@pdl.com; Jennifer Williams, Cook Williams Communications, Inc., +1-360-668-3701, jennifer@cwcomm.org